Skip to main content

levetiracetam

NDC 36000-352 · Baxter Healthcare Corporation

Generic namelevetiracetam
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)LEVETIRACETAM
Strength5 mg/mL
Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

36000-352-40 — 24 BAG in 1 CARTON (36000-352-40) / 100 mL in 1 BAG (36000-352-01)

Billed under HCPCS

J1958 — Injection, levetiracetam in sodium chloride, 5 mg Medicare Part B payment limit (ASP + 6%): $0.03

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

25021-795 — levetiracetam, 27808-263 — Levetiracetam, 27808-264 — Levetiracetam, 27808-265 — Levetiracetam, 27808-266 — Levetiracetam, 31722-536 — Levetiracetam, 31722-537 — Levetiracetam, 31722-538 — Levetiracetam, 31722-539 — Levetiracetam, 31722-574 — Levetiracetam oral, 36000-354 — levetiracetam, 36000-356 — levetiracetam, 39328-511 — Levetiracetam, 42571-331 — LEVETIRACETAM, 43063-499 — Levetiracetam, 43063-617 — Levetiracetam, 43485-101 — levetiracetam, 43485-102 — levetiracetam, 43485-103 — levetiracetam, 43485-104 — levetiracetam, +277 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources